Safety of in Utero and Neonatal Antiretroviral Exposure: Cognitive and Academic Outcomes in HIV-exposed, Uninfected Children 5-13 Years of Age

Overview

Journal Pediatr Infect Dis J

Specialty Pediatrics

Date 2014 Nov 1

PMID 25361407

Citations 18

Authors

Molly L Nozyce

Yanling Huo

Paige L Williams

Suad Kapetanovic

Rohan Hazra

Sharon Nichols

Scott Hunter

Renee Smith

George R Seage 3rd

Patricia A Sirois

Affiliations

Soon will be listed here.

Abstract

Background: Long-term effects of in utero and neonatal antiretroviral (ARV) exposure on cognitive and academic development in HIV-exposed, uninfected school-age children are unknown.

Methods: HIV-exposed, uninfected children, ages 5-13 years, in Pediatric HIV/AIDS Cohort Study Surveillance Monitoring for Antiretroviral Treatment Toxicities, a US-based multisite cohort study, completed age-appropriate Wechsler intelligence and academic scales (WPPSI-III, WASI, WIAT-II-A). Associations between cognitive and academic outcomes and in utero ARV exposure by regimen, class and individual ARVs were evaluated, adjusting for potential confounders.

Results: Children completing WPPSI-IIIs (n = 350) were 49% male, 74% Black, 25% Hispanic; WASI (n = 337) and WIAT-II-A (n = 415) cohorts were similar. The percentage exposed to combination ARV (cARV) was 84% (WPPSI-III), 64% (WASI) and 67% (WIAT-II-A). Among ARV-exposed children, there were no significant associations between any ARV regimen or class and any cognitive or academic outcome. In addition, in both unadjusted models and after adjustment for caregiver IQ, sociodemographic factors and maternal health and substance use during pregnancy, no individual ARV drug was associated with significantly lower cognitive or academic scores. Factors typically associated with lower cognitive and academic scores in the general population, such as prematurity, small for gestational age, maternal alcohol use and lower maternal cognitive status, were also associated with lower scores in this study.

Conclusions: Overall, the safety of prenatal and neonatal ARV use was supported.

Citing Articles

HIV Infection and Exposure Increases Cariogenic Taxa, Reduces Taxonomic Turnover, and Homogenizes Spatial Differentiation for the Supragingival Microbiome.

Mann A, Aumend C, Crull S, OConnell L, Osagie E, Akhigbe P Res Sq. 2024; .

PMID: 39149457 PMC: 11326420. DOI: 10.21203/rs.3.rs-4720457/v1.

Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone.

Dhume S, Balogun K, Sarkar A, Acosta S, Mount H, Cahill L Front Mol Neurosci. 2024; 17:1376681.

PMID: 38646101 PMC: 11027900. DOI: 10.3389/fnmol.2024.1376681.

Impact of HIV on the Oral Microbiome of Children Living in Sub-Saharan Africa, Determined by Using an Gene Fragment Metataxonomic Approach.

Mann A, OConnell L, Osagie E, Akhigbe P, Obuekwe O, Omoigberale A Microbiol Spectr. 2023; 11(4):e0087123.

PMID: 37428077 PMC: 10434123. DOI: 10.1128/spectrum.00871-23.

In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.

Yao T, Malee K, Zhang J, Smith R, Redmond S, Rice M AIDS Patient Care STDS. 2023; 37(3):119-130.

PMID: 36827595 PMC: 10081721. DOI: 10.1089/apc.2022.0189.

Ageing with HIV: a longitudinal study of markers of resilience in young adults with perinatal exposure to HIV, with or without perinatally acquired HIV.

Sirois P, Huo Y, Nozyce M, Garvie P, Harris L, Malee K J Int AIDS Soc. 2022; 25 Suppl 4:e25982.

PMID: 36176020 PMC: 9522985. DOI: 10.1002/jia2.25982.

References

Williams P, Marino M, Malee K, Brogly S, Hughes M, Mofenson L . Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants. Pediatrics. 2010; 125(2):e250-60. PMC: 2951128. DOI: 10.1542/peds.2009-1112. View

Le Doare K, Bland R, Newell M . Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics. 2012; 130(5):e1326-44. DOI: 10.1542/peds.2012-0405. View

McLoyd V . Socioeconomic disadvantage and child development. Am Psychol. 1998; 53(2):185-204. DOI: 10.1037//0003-066x.53.2.185. View

Alimenti A, Forbes J, Oberlander T, Money D, Grunau R, Papsdorf M . A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. Pediatrics. 2006; 118(4):e1139-45. DOI: 10.1542/peds.2006-0525. View

Heidari S, Mofenson L, Cotton M, Marlink R, Cahn P, Katabira E . Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011; 57(4):290-6. DOI: 10.1097/QAI.0b013e318221c56a. View

Powis K, Kitch D, Ogwu A, Hughes M, Lockman S, Leidner J . Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis. 2011; 204(4):506-14. PMC: 3144169. DOI: 10.1093/infdis/jir307. View

Whitmore S, Zhang X, Taylor A, Blair J . Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006. J Acquir Immune Defic Syndr. 2011; 57(3):218-22. DOI: 10.1097/QAI.0b013e3182167dec. View

Brooks-Gunn J, Duncan G . The effects of poverty on children. Future Child. 1997; 7(2):55-71. View

Divi R, Leonard S, Walker B, Kuo M, Shockley M, St Claire M . Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age. Toxicol Sci. 2007; 99(1):203-13. DOI: 10.1093/toxsci/kfm143. View

10.

Brogly S, Ylitalo N, Mofenson L, Oleske J, Van Dyke R, Crain M . In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS. 2007; 21(8):929-38. DOI: 10.1097/QAD.0b013e3280d5a786. View

11.

Smith R, Chernoff M, Williams P, Malee K, Sirois P, Kammerer B . Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J. 2012; 31(6):592-8. PMC: 3424347. DOI: 10.1097/INF.0b013e318253844b. View

12.

Brackis-Cott E, Kang E, Dolezal C, Abrams E, Mellins C . The impact of perinatal HIV infection on older school-aged children's and adolescents' receptive language and word recognition skills. AIDS Patient Care STDS. 2009; 23(6):415-21. PMC: 2818481. DOI: 10.1089/apc.2008.0197. View

13.

Thorne C, Newell M . Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?. Drug Saf. 2007; 30(3):203-13. DOI: 10.2165/00002018-200730030-00004. View

14.

Sirois P, Huo Y, Williams P, Malee K, Garvie P, Kammerer B . Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants. Pediatr Infect Dis J. 2013; 32(6):648-55. PMC: 3723344. DOI: 10.1097/INF.0b013e318284129a. View

15.

Griner R, Williams P, Read J, Seage 3rd G, Crain M, Yogev R . In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Patient Care STDS. 2011; 25(7):385-94. PMC: 3125552. DOI: 10.1089/apc.2011.0068. View

16.

Poirier M, Olivero O, Walker D, Walker V . Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol Appl Pharmacol. 2004; 199(2):151-61. DOI: 10.1016/j.taap.2003.11.034. View

17.

Ivanovic J, Nicastri E, Anceschi M, Ascenzi P, Signore F, Pisani G . Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women. Curr HIV Res. 2009; 7(6):620-5. DOI: 10.2174/157016209789973628. View

18.

Rice M, Zeldow B, Siberry G, Purswani M, Malee K, Hoffman H . Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants. Pediatr Infect Dis J. 2013; 32(10):e406-13. PMC: 3785009. DOI: 10.1097/INF.0b013e31829b80ee. View

19.

Calamandrei G, Valanzano A, Puopolo M, Aloe L . Developmental exposure to the antiretroviral drug zidovudine increases brain levels of brain-derived neurotrophic factor in mice. Neurosci Lett. 2002; 333(2):111-4. DOI: 10.1016/s0304-3940(02)01023-6. View

20.

Culnane M, Fowler M, Lee S, McSherry G, Brady M, ODonnell K . Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA. 1999; 281(2):151-7. DOI: 10.1001/jama.281.2.151. View